未接種者なら定期的なヨガの浄化法「ネティ（鼻うがい）」によりノーリスクで「ワクチン」の十倍以上の入院予防効果が得られる

【研究】
高リスクのコロナ外来患者への“生理食塩水による鼻うがい”で、入院する確率が全国平均の8分の1に減ったhttps://t.co/cDfLj9eMNd

スティーブ・キルシュ
「何十億ドルもの費用と、1年以上の時間を浪費して、ワクチンに傾倒する前に、なんで簡単なことから始めなかったんだ？」 pic.twitter.com/8omP57fSTW

— タマホイ🎶🍃🗻🧷 (@Tamama0306) November 29, 2022

 

2022 Aug 25;1455613221123737.

doi: 10.1177/01455613221123737. Online ahead of print.

Rapid initiation of nasal saline irrigation to reduce severity in high-risk COVID+ outpatients           

         Abstract

Objective: To determine whether initiating saline nasal irrigation after COVID-19 diagnosis reduces hospitalization and death in high-risk outpatients compared with observational controls, and if irrigant composition impacts severity.

Methods: Participants 55 and older were enrolled within 24 hours of a + PCR COVID-19 test between September 24 and December 21, 2020. Among 826 screened, 79 participants were enrolled and randomly assigned to add 2.5 mL povidone-iodine 10% or 2.5 mL sodium bicarbonate to 240 mL of isotonic nasal irrigation twice daily for 14 days. The primary outcome was hospitalization or death from COVID-19 within 28 days of enrollment by daily self-report confirmed with phone calls and hospital records, compared to the CDC Surveillance Dataset covering the same time. Secondary outcomes compared symptom resolution by irrigant additive.

Results: Seventy-nine high-risk participants were enrolled (mean [SD] age, 64 [8] years; 36 [46%] women; 71% Non-Hispanic White), with mean BMI 30.3. Analyzed by intention-to-treat, by day 28, COVID-19 symptoms resulted in one ED visit and no hospitalizations in 42 irrigating with alkalinization, one hospitalization of 37 in the povidone-iodine group, (1.27%) and no deaths. Of nearly three million CDC cases, 9.47% were known to be hospitalized, with an additional 1.5% mortality in those without hospitalization data. Age, sex, and percentage with pre-existing conditions did not significantly differ by exact binomial test from the CDC dataset, while reported race and hospitalization rate did. The total risk of hospitalization or death (11%) was 8.57 times that of enrolled nasal irrigation participants (SE = 2.74; P = .006). Sixty-two participants completed daily surveys (78%), averaging 1.8 irrigations/day. Eleven reported irrigation-related complaints and four discontinued use. Symptom resolution was more likely for those reporting twice daily irrigation (X² = 8.728, P = .0031) regardless of additive.

Conclusion: SARS-CoV-2+ participants initiating nasal irrigation were over 8 times less likely to be hospitalized than the national rate.

     https://pubmed.ncbi.nlm.nih.gov/36007135/

 

鼻うがいｷﾀ━(ﾟ∀ﾟ)━!

塩分濃度0.9%で、30℃くらいのぬるま湯使うと痛くないお。逆に冷たい水道水でやると、ツーン！ギョェー💦ってなる。
ほんの少し（数滴で十分）次亜塩素酸水入れると殺菌力爆上がり。

— PDSPDCASDCA (@PDSPDCASDCA1) November 29, 2022

 接種者はアップデートレッツゴー！（爆ｗｗｗｗｗｗｗｗｗｗｗｗｗ